-+ 0.00%
-+ 0.00%
-+ 0.00%

APTEVO THERAPEUTICS - EXPECTS TO ENTER IND-ENABLING STUDIES FOR APVO451 IN 1H2027 - SEC FILING

Reuters·09/24/2026 12:11:56

Please log in to view news